![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
隆卡斯图西马布特西林用于治疗复发性或耐火性扩散性大B细胞淋巴瘤
Luis Miguel Juárez-Salcedo1, Santosh Nimkar2, Ana María Corazón3
1Hematology Department, La Princesa University Hospital, 28006 Madrid, Spain.
International journal of molecular sciences
|July 27, 2024
概括
隆卡斯图西马布特西林为扩散性大B细胞淋巴瘤 (DLBCL) 患者提供了一种新的免疫疗法选择,这些患者在初始治疗后复发. 这种抗体-药物结合物在耐火DLBCL病例中显示出有效性和可管理的安全性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 显著一部分扩散型大B细胞淋巴瘤 (DLBCL) 患者是免疫化学疗法后耐药或复发的.
- 自主干细胞移植或CAR T细胞疗法后出现第二次复发的患者存在有限的有效治疗选择.
研究的目的:
- 为了审查loncastuximabtesirine的作用机制.
- 总结支持其FDA批准的临床数据.
- 探索涉及loncastuximab tesirine的新型治疗策略.
主要方法:
- 审查现有的临床研究和FDA文档.
- 分析loncastuximab tesirine作为抗CD19抗体与药物结合物的作用机制.
- 来自临床试验的安全性和疗效数据的评估.
主要成果:
- 隆卡斯图西马布特西林在治疗耐火性DLBCL方面表现出有效性.
- 观察到的主要不良反应包括中性质减退,血小板减退和肝酶升高.
- 临床数据已经支持FDA的接受.
结论:
- 隆卡斯图西马布特西林代表了复发性或耐火性DLBCL免疫疗法的有前途的进步.
- 了解其机制和安全概况对于临床应用至关重要.
- 对组合疗法的进一步研究可能会提高治疗结果.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
10:19Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
Published on: May 12, 2023
1.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498